General Programme - Clinical Trials
|Target group||SME, Start-up|
|Type of service||Funding, Advice|
|Förderinstrument||C3 E Einzelprojekt - Experimentelle Entwicklung|
|FFG Unit of organisation||General programmes|
Clinical Trials within General Programme strengthen the competitiviness of companies based in Austria by funding all transaction costs for the clinical study. Start-ups, small and medium-sized companies (less than 250 employees) are the fund recipients. The funding level is max. € 1,5 million each for relevant study costs by funding with low-intrest loans (duration 5 years). Submission is possible at any time. Special features: The evaluation is carried out throughout the General Programme scoreboard and some additonal guidelines for Clinical Studies funding. The study has to be carried out by a SME in co-operation with an Austrian clinical partner.